Because the CONCERTA tablet is nondeformable and does not appreciably transform in shape within the GI tract, CONCERTA must not ordinarily be administered to patients with preexisting intense gastrointestinal narrowing (pathologic or iatrogenic, such as: esophageal motility Diseases, small bowel inflammatory ailment, "shorter gut" syndrome due to a